hydroxychloroquine has been researched along with Heart Defects, Congenital in 2 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Heart Defects, Congenital: Developmental abnormalities involving structures of the heart. These defects are present at birth but may be discovered later in life.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Lewis, MJ | 1 |
Anderson, BR | 1 |
Fremed, M | 1 |
Argenio, M | 1 |
Krishnan, U | 1 |
Weller, R | 1 |
Levasseur, S | 1 |
Sommer, R | 1 |
Lytrivi, ID | 1 |
Bacha, EA | 1 |
Vincent, J | 1 |
Chung, WK | 1 |
Rosenzweig, EB | 1 |
Starc, TJ | 1 |
Rosenbaum, M | 1 |
Pisoni, CN | 1 |
Brucato, A | 1 |
Ruffatti, A | 1 |
Espinosa, G | 1 |
Cervera, R | 1 |
Belmonte-Serrano, M | 1 |
Sánchez-Román, J | 1 |
García-Hernández, FG | 1 |
Tincani, A | 1 |
Bertero, MT | 1 |
Doria, A | 1 |
Hughes, GR | 1 |
Khamashta, MA | 1 |
2 other studies available for hydroxychloroquine and Heart Defects, Congenital
Article | Year |
---|---|
Impact of Coronavirus Disease 2019 (COVID-19) on Patients With Congenital Heart Disease Across the Lifespan: The Experience of an Academic Congenital Heart Disease Center in New York City.
Topics: Academic Medical Centers; Adult; Aged; Azithromycin; Cohort Studies; COVID-19; Female; Genetic Disea | 2020 |
Failure of intravenous immunoglobulin to prevent congenital heart block: Findings of a multicenter, prospective, observational study.
Topics: Autoantigens; Dexamethasone; Drug Therapy, Combination; Female; Heart Block; Heart Defects, Congenit | 2010 |